Hongki Gwak (HongKi Gwak)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Emergency Department

Positive Breast Cancer

Coronavirus Disease

Chemotherapy Induced

Top Venues

Journal of clinical medicine

Journal of breast cancer

Annals of surgical treatment and research

This page only lists publications with an associated author ORCID identifier.

Publications

Sang Seok Woo, Hongki Gwak, Ki Hyun Kim, Jun Won Lee, Jai Koo Choi, Insuck Suh, Seong Hwan Kim
Evaluation of Esthetic Results after Mass Removal with Elliptical Skin Excision Using Ultrasonography to Measure Skin Thickness. Journal of clinical medicine 13 (5) (2024)
Sang Seok Woo, Hongki Gwak, Ki Hyun Kim, Jun Won Lee, Jai Koo Choi, Insuck Suh, Seong Hwan Kim
Evaluation of Esthetic Results after Mass Removal with Elliptical Skin Excision Using Ultrasonography to Measure Skin Thickness. Journal of clinical medicine 13 (5) (2024)
Sang Seok Woo, Hongki Gwak, Seung Seog Han, In Suck Suh, Seong Hwan Kim
Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia. Journal of clinical medicine 12 (8) (2023)
Sang Seok Woo, Hongki Gwak, Seung Seog Han, In Suck Suh, Seong Hwan Kim
Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia. Journal of clinical medicine 12 (8) (2023)
Hongki Gwak, Sang Seok Woo, Se Jeong Oh, Jee Ye Kim, Hee-Chul Shin, Hyun Jo Youn, Jung Whan Chun, Dasom Lee, Seong Hwan Kim
A Comparison of the Prognostic Effects of Fine Needle Aspiration and Core Needle Biopsy in Patients with Breast Cancer: A Nationwide Multicenter Prospective Registry. Cancers 15 (18) (2023)
Sang Seok Woo, Hongki Gwak, Seung Seog Han, In Suck Suh, Seong Hwan Kim
Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia. Journal of clinical medicine 12 (8) (2023)
Sang Seok Woo, Hongki Gwak, Seung Seog Han, In Suck Suh, Seong Hwan Kim
Evaluation of the Pinhole Method Using Carbon Dioxide Laser on Facial Telangiectasia. Journal of clinical medicine 12 (8) (2023)
Hongki Gwak, Seung-Taek Lim, Ye-Won Jeon, Hyung Soon Park, Seong Hwan Kim, Young-Jin Suh
COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim. Journal of clinical medicine 11 (23) (2022)
Hongki Gwak, Seung-Taek Lim, Ye-Won Jeon, Hyung Soon Park, Seong Hwan Kim, Young-Jin Suh
COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim. Journal of clinical medicine 11 (23) (2022)
Hongki Gwak, Seung-Taek Lim, Ye-Won Jeon, Hyung Soon Park, Seong Hwan Kim, Young-Jin Suh
COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim. Journal of clinical medicine 11 (23) (2022)
Ye Won Jeon, Seung Taek Lim, Hongki Gwak, Seon Young Park, Juhee Shin, Hye Sug Han, Young Jin Suh
Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy. Annals of surgical treatment and research 100 (2) (2021)
Jean Schneider, Hyouk Jin Lee, Seok-Jin Nam, Soo Jung Lee, Jin Hyang Jung, Sung Hoo Jung, Seung Taek Lim, Ye Won Jeon, Hongki Gwak
Relative Survival Benefit by Hormonal Receptor Status of Adding Trastuzumab to Neoadjuvant Chemotherapy in Breast Cancer Patients. Journal of breast cancer 23 (3) (2020)
Ye Won Jeon, Seung Taek Lim, Hongki Gwak, Seon Young Park, Young Jin Suh
Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy. Journal of breast cancer 23 (5) (2020)
Seung Taek Lim, Ye Won Jeon, Hongki Gwak, Young Jin Suh
Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer. Journal of breast cancer 23 (5) (2020)